Vanguard Capital Management
FENC icon

Vanguard Capital Management’s Fennec Pharmaceuticals FENC Stock Holding History

Vanguard Capital Management’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.02M Sell
839,306
-57,838
-6% -$472K ﹤0.01% 2879
2026
Q1 		$5.52M Buy
+897,144
New +$6.93M ﹤0.01% 3020

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
PCA
Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
PCM
Potomac Capital Management New York $147M AUM

Vanguard Capital Management's FENC Position: Q2 2026 in Review

Vanguard Capital Management reduced its Fennec Pharmaceuticals (FENC) stake by 6.4% in Q2 2026, selling an estimated $472K and leaving 839,306 shares worth $9.02M. The position accounts for ﹤0.01% of the portfolio, ranked #2879.

Vanguard Capital Management first reported a position in FENC in Q1 2026 and has held it in 2 quarters since. 105 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

  • Vanguard Capital Management held 839,306 shares of Fennec Pharmaceuticals worth $9.02M as of Q2 2026.
  • Vanguard Capital Management sold 57,838 Fennec Pharmaceuticals shares in Q2 2026, an estimated $472K.
  • Fennec Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #2879 holding.
  • Vanguard Capital Management first reported a position in Fennec Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 105 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.